Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 3272 of 6372
-
Can smart sensors ease the burden on dementia caregivers?
Symptom relief CompletedThis study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment by inte…
Sponsor: University of California, Berkeley • Aim: Symptom relief
Last updated Jun 26, 2026 18:12 UTC
-
Which blood thinner is safer for heart patients with low platelets?
Disease control Recruiting nowThe use of clopidogrel as part of DAPT will be associated with lower bleeding rates compared to ticagrelor in patients with chronic thrombocytopenia requiring Percutaneous intervention (PCI )with Drug Eluting Stent (DES) or Bare Metal Stint(BMS).
Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug IBI363 aims to supercharge immune system against tough cancers
Disease control OngoingThis is a Phase 1, open-label, multicenter, dose-escalation study designed to evaluate the safety, tolerability, and DLTs to establish the maximum tolerated dose (MTD) or maximum administered dose (MAD), and the RP2D of sequential doses of IBI363 (study drug) in subjects with adv…
Phase 1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New study: could starting PT right away get young athletes back in the game faster?
Symptom relief CompletedSpondylolysis, a stress fracture in the pars interarticularis of a lumbar vertebra, is the most common identifiable cause of low back pain (LBP) in adolescent athletes, occurring in 14-30% of athletes who experience LBP. Spondylolysis can cause significant pain and disability and…
Sponsor: Nationwide Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New study tracks how well thyroid ablation eases symptoms
Symptom relief By invitation onlyThe purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 26, 2026 17:12 UTC
-
Bridging the service gap: advocacy program tailored for latinx families of autistic teens
Knowledge-focused CompletedWhen youth with autism spectrum disorder (ASD) transition from school to adult services, they fall off a "service cliff." To increase access to services, the investigators developed the ASSIST program, which teaches parents how to advocate for adult services on behalf of youth wi…
Sponsor: Vanderbilt University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New prosthetic grows with kids: no more frequent replacements?
Symptom relief CompletedAn immediate fit adjustable prosthetic system is being investigated for children. The age range being recruited is from 3 years up to 18 years old. Phase I of this study will involve developing a final prototype by conducting in-lab testing on children with limb loss. Phase II wi…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Blood test may guide depression treatment
Knowledge-focused CompletedThe study aims to assess whether providing Clinical Decision Support Software (CDSS) information improves the pharmacological response in patients with depression. The CDSS integrates genomic, clinical, and blood biomarker data to assist psychiatrists in selecting the most approp…
Sponsor: Neomente SAS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New drug tested for Long-Term safety in kids with rare muscle disease
Disease control By invitation onlyThe purpose of this trial is to evaluate the long-term safety of efgartigimod IV and efgartigimod PH20 SC administered to participants with gMG in the antecedent studies, ARGX-113-2006 and ARGX-113-2207, respectively. Participants will receive efgartigimod IV or efgartigimod PH2…
Phase 2/3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Dialysis dilemma: which access surgery is safer for seniors?
Disease control OngoingThis study is to prospectively compare the effectiveness and safety of the two types of arteriovenous access placement (fistula or graft) in older adults with end stage kidney disease and multiple chronic conditions
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New glaucoma surgery under the microscope: 300 patients tracked for 2 years
Disease control OngoingThis observational study will enroll adults with open angle glaucoma (OAG) who had surgery to reduce intraocular pressure (IOP) using the CycloPen Micro-Interventional System. Consenting participants will be followed for 24 months after their surgery. Data regarding IOP, use of …
Sponsor: Iantrek, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
VR goggles could replace pills for teen surgery anxiety
Symptom relief CompletedIn this randomized control trial, investigators would like to assess as primary objective the effectiveness of VR in anxiolysis via using State Trait Anxiety- Inventory test various time during the perioperative period with recorded physiologic data. As a secondary objective they…
Sponsor: Semmelweis University • Aim: Symptom relief
Last updated Jun 26, 2026 14:40 UTC
-
New combo therapy aims to clear hepatitis b and d in 20-patient trial
Disease control CompletedPrimary objective: To evaluate the safety and tolerability of sequential administration of P1101 and anti-PD1 in patient with chronic hepatitis B or D infection Secondary objectives: 1. To explore HBsAg loss and kinetics during the study period 2. To assess the anti-viral effe…
Phase 1 • Sponsor: PharmaEssentia • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a simple exercise program keep zuni elders on their feet?
Disease control CompletedFalls and fall-related injuries are major health risks in American Indian elders. The data showed 52 percent of Zuni elders reporting a fall during the past year, which is significantly higher than the US national average of one out of three adults older then 65 years. In partner…
Sponsor: University of New Mexico • Aim: Disease control
Last updated Jun 26, 2026 12:58 UTC
-
New 3D MRI scan could replace needle test for liver patients
Diagnosis Recruiting nowHow to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis. We plan to compare the ability of three demensional-magn…
Sponsor: Shengjing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New drug XMT-1660 enters first human tests for Hard-to-Treat cancers
Disease control Recruiting nowA Study of Emi-Le in Participants with Solid Tumors
Phase 1/2 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Sleep disorder study could pave way for Parkinson's prevention
Knowledge-focused By invitation onlyThis study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo targets tough cancers in early trial
Disease control Recruiting nowThis is a first-in-human, Phase 1/2, open-label, study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of Mavrostobart (PT199) alone and in combination with a PD-1 inhibitor or chemotherapy.
Phase 1/2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Exercise program aims to protect hearts of black men on prostate cancer treatment
Disease control Recruiting nowThe purpose of this research is to determine whether a 16-week culturally tailored, technology-based, aerobic and resistance exercise intervention improves cardiovascular risk factors in Black men diagnosed with prostate cancer and are undergoing androgen deprivation therapy (ADT…
Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could a diabetes drug shield the brains of HIV patients?
Disease control CompletedMetabolic syndrome is a constellation of risk factors for cardiovascular disease and type 2 diabetes mellitus which frequently occur together. Data is emerging suggesting metabolic syndrome causes brain disease by contributing to blood vessel damage and inflammation. People livin…
Phase 2 • Sponsor: University of Stellenbosch • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC